减值准备

Search documents
航天科技控股集团股份有限公司2025年第一季度报告
Shang Hai Zheng Quan Bao· 2025-04-30 05:18
Core Viewpoint - The company has announced the provision for asset impairment, reflecting a cautious approach in accordance with accounting standards and regulations [8][11][24]. Financial Data - The first quarter report for 2025 has not been audited [3][7]. - The company has reported a total provision for bad debts of 6,890,455.28 yuan, with a reversal of 2,020,373.58 yuan [9]. - The provision for inventory impairment amounts to 133,476.69 yuan, with a write-off of 2,048.70 yuan [10]. Shareholder Information - The company has confirmed that there are no changes in the top ten shareholders due to the lending or returning of shares [5]. Board and Supervisory Committee Decisions - The board and supervisory committee have both approved the asset impairment provision, confirming its compliance with accounting standards and reflecting the company's financial status accurately [12][24]. - The board meeting held on April 29, 2025, had full attendance and passed the resolution with unanimous support [16][20].
山东宏创铝业控股股份有限公司2025年第一季度报告
Shang Hai Zheng Quan Bao· 2025-04-30 02:35
Core Viewpoint - The company has disclosed its financial performance and significant events, including the issuance of new shares and the provision for asset impairment, reflecting its ongoing financial management and strategic adjustments in response to market conditions [3][6][15]. Financial Data Summary - The company reported a total asset impairment provision of 27,617,741.97 yuan for the first quarter of 2025, which will reduce the net profit attributable to the parent company by 27,588,451.58 yuan after considering tax effects [15][17]. - The company has not restated or adjusted previous years' financial data, indicating stability in its accounting practices [3][4]. Share Issuance and Capital Management - The company received approval from the China Securities Regulatory Commission to issue up to 27,792 million new shares, with the issuance completed on August 4, 2023, increasing the total shares from 926,400,000 to 1,136,373,753 [6][7]. - The company plans to continue using idle raised funds for cash management, with a limit of 400 million yuan for a period not exceeding 12 months [10]. Asset Impairment and Financial Health - The company conducted a comprehensive review of its assets, including inventory and receivables, leading to the decision to provision for asset impairment based on prudence and market conditions [16][18]. - The audit committee has confirmed that the asset impairment provision is in accordance with accounting standards and reflects the company's financial condition accurately [18]. Corporate Governance and Accountability - The board of directors and senior management have guaranteed the accuracy and completeness of the quarterly report, accepting legal responsibility for any misstatements [2][3].
迈得医疗工业设备股份有限公司 2025年第一季度报告
Zheng Quan Ri Bao· 2025-04-30 00:51
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688310 证券简称:迈得医疗 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假 记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 对公司将《公开发行证券的公司信息披露解释性公告第1号——非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的,以及将《公开发行证券的公司信息披露解释性公告第1号——非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目,应说明原因。 □适用 √不适用 (三) 主要会计数据、财务指标发生变动的情况、原因 √适用 □ ...
上海仁度生物科技股份有限公司 2025年第一季度报告
Zheng Quan Ri Bao· 2025-04-30 00:51
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688193 证券简称:仁度生物 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假 记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 对公司将《公开发行证券的公司信息披露解释性公告第1号——非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的,以及将《公开发行证券的公司信息披露解释性公告第1号——非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目,应说明原因。 □适用 √不适用 (三) 主要会计数据、财务指标发生变动的情况、原因 √适用 □ ...
江苏硕世生物科技股份有限公司 2025年第一季度报告
Zheng Quan Ri Bao· 2025-04-30 00:18
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688399 证券简称:硕世生物 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假 记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 2025年第一季度,外部环境压力仍然存在,公司通过海外市场提速、内部精细化管理举措的不断落地, 积极应对市场挑战,业务继续向正常发展轨道回归。报告期内公司实现营业收入0.92亿元,同比增长 0.54%,环比增长12.37%,呈现稳步恢复态势。 单位:元 币种:人民币 收入端:报告期内,公司海外市场保持良好增长势头。得益于先前的产品认证和海外市场的战略部署, 公司海外收入同比增长69.00%。 利润端:随着体外诊断行业集采在全国 ...
东方证券(600958):投资收益同环比高增超100%,单季股质减值准备冲回
Shenwan Hongyuan Securities· 2025-04-29 15:31
Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a significant increase in investment income, with both year-on-year and quarter-on-quarter growth exceeding 100%. The quarterly stock quality impairment provision was reversed, contributing positively to profits [1][6] - For Q1 2025, the company achieved revenue of 5.38 billion yuan, a year-on-year increase of 49.1% and a quarter-on-quarter increase of 5.3%. The net profit attributable to the parent company was 1.44 billion yuan, representing a year-on-year increase of 62.0% and a quarter-on-quarter increase of 28.8 times [4][6] - The company’s weighted ROE for Q1 2025 was 1.79%, an increase of 0.68 percentage points year-on-year [4] Financial Data and Profit Forecast - The company’s revenue for 2025 is projected to be 24.69 billion yuan, with a year-on-year growth rate of 28.7% [5] - The net profit attributable to the parent company for 2025 is estimated at 5.81 billion yuan, reflecting a year-on-year growth of 73.3% [5] - The annualized investment return rate for Q1 2025 reached 8.99%, compared to 5.32% in 2024 and 3.34% in Q1 2024 [6] Business Performance - The company’s management expenses for Q1 2025 were 2.21 billion yuan, showing a year-on-year increase of 38% but a quarter-on-quarter decrease of 18%, leading to a net profit margin of 27%, up 2 percentage points year-on-year [6] - The company’s brokerage and margin financing performance was below industry standards, with a decline in customer assets by 11% compared to the end of 2024 [6] - The company’s financial investment scale at the end of Q1 2025 was 226 billion yuan, a 1% increase from the end of the previous year [6]
智度科技股份有限公司
Shang Hai Zheng Quan Bao· 2025-04-29 15:24
2024年,公司及子公司在不影响公司正常经营资金需求和确保资金安全的前提下,使用部分暂时闲置的 自有资金进行委托理财,总额度不超过10亿元。截至2024年12月31日,未到期理财余额为5.13亿元。 具体内容详见公司同日发布在巨潮资讯网(www.cninfo.com.cn)上的《智度科技股份有限公司关于 2024年度证券投资情况的专项说明》。 (十)《智度科技股份有限公司2025年度董事薪酬方案》 因该事项与全体董事存在利害关系,因此全体董事回避表决,本议案将直接提交公司股东会审议。 具体内容详见公司同日发布在巨潮资讯网(www.cninfo.com.cn)上的《智度科技股份有限公司2025年 度董事、监事及高级管理人员薪酬方案》。 登录新浪财经APP 搜索【信披】查看更多考评等级 (九)《智度科技股份有限公司关于2024年度证券投资情况的专项说明》 表决结果:五票同意、零票反对、零票弃权。本议案获得通过。 表决结果:三票同意、零票反对、零票弃权。本议案获得通过。 关联董事陆宏达先生和刘广飞先生回避表决。 具体内容详见公司同日发布在巨潮资讯网(www.cninfo.com.cn)上的《智度科技股份有限公司关于 ...
泰豪科技股份有限公司
Shang Hai Zheng Quan Bao· 2025-04-29 14:14
Group 1 - The company announced the introduction of strategic investors for its wholly-owned subsidiary, Jiangxi Taihao Military Industry Group Co., Ltd., with a total capital increase of 798.2851 million yuan [2][4] - After the capital increase, the strategic investors will hold a total of 27.88% equity in Taihao Military Industry, which will remain a controlled subsidiary of the company [2][4] - The strategic investors include Beijing Guofa Aviation Engine Industry Investment Fund Center, Yulin Coal Resource Transformation Guidance Fund, Chongqing Taihefeng Private Equity Investment Fund, among others [2][4] Group 2 - The company is currently advancing the process of acquiring a total of 27.46% equity in Taihao Military Industry through the issuance of shares [4] - Recent agreements have been signed to amend the original investment agreements, terminating certain special rights previously held by the investors, such as the "repurchase right" [4][6] - The new agreements will take effect upon signing and will have the same legal effect as the original agreements, with certain clauses being suspended until the transaction is approved by the Shanghai Stock Exchange [6][7] Group 3 - The company reported a total asset impairment provision of 536,436,183.54 yuan for the year 2024, which will reduce the pre-tax profit for the consolidated financial statements [10][19] - The company also wrote off assets totaling 48,957,739.60 yuan, which will increase the pre-tax profit for the consolidated financial statements by 2,858,445.79 yuan [10][19] - The overall impact of the asset impairment and write-off will result in a net reduction of 533,577,737.75 yuan in the pre-tax profit for the year 2024 [19] Group 4 - The company reported a net loss of 991,034,446.51 yuan for the year 2024, leading to an unremedied loss amounting to one-third of the paid-in capital [22][23] - The primary reasons for the loss include delays in military projects and a decline in profitability for its subsidiary, Shanghai Hongsheng System Engineering Co., Ltd., due to intensified industry competition [23] - The company plans to accelerate military project progress, enhance market expansion in the emergency power supply sector, increase R&D investment, and continue to divest inefficient assets [23][24] Group 5 - The company plans to apply for a total comprehensive credit limit of up to 7.29 billion yuan for the year 2025, with a guarantee amount not exceeding 2.49 billion yuan for its subsidiaries [38][39] - The credit limit will be valid from the date of approval by the 2024 annual general meeting until the 2025 annual general meeting [38][39] - The company has no overdue guarantees and is within the authorized guarantee limit approved by the shareholders [41][56] Group 6 - The company intends to renew its contract with Da Xin Accounting Firm for the 2025 financial audit and internal control audit [60] - Da Xin Accounting Firm has extensive experience in securities services and has provided audit services to over 10,000 companies [62] - The renewal of the accounting firm is subject to approval at the upcoming shareholders' meeting [60][62]
中信国安信息产业股份有限公司
Shang Hai Zheng Quan Bao· 2025-04-29 14:14
Group 1 - The company reported a beginning balance of accounts receivable impairment provision of 40.16 million yuan for 2024, with an additional provision of 5.45 million yuan and a write-off of 6.81 million yuan, resulting in an ending balance of 38.79 million yuan [1] - The beginning balance of other receivables impairment provision was 1.40 billion yuan, with a provision of 141.98 million yuan and a write-off of 2.83 million yuan, leading to an ending balance of 1.54 billion yuan [2] - The beginning balance of dividend receivables impairment provision was 14.12 million yuan, with a provision of -0.09 million yuan and a write-off of 4.17 million yuan, resulting in an ending balance of 9.86 million yuan [2] Group 2 - The company made a provision for long-term equity investment impairment of 10.18 million yuan for the year 2024 [3] - The company announced a change in accounting policy due to the revised accounting standards issued by the Ministry of Finance, which will not significantly impact the company's financial status, operating results, or cash flow [6][13] - The new accounting policy will be effective from January 1, 2024, and aims to reflect the company's financial condition and operating results more objectively and fairly [7][10] Group 3 - The company will hold an online performance briefing on May 16, 2025, to discuss the 2024 annual report and allow investors to ask questions in advance [14][15] - The company reported a negative retained earnings balance of 3.49 billion yuan as of December 31, 2024, which exceeds one-third of the company's paid-in capital, necessitating a shareholders' meeting [24][26] - The company plans to not distribute cash dividends or issue bonus shares for the 2024 fiscal year due to the negative retained earnings [24][70]
荣安地产股份有限公司
Shang Hai Zheng Quan Bao· 2025-04-29 14:14
Group 1 - The company has recognized an asset impairment provision of 138,394.48 million yuan for the year 2024, which will reduce the total profit by the same amount and decrease the net profit attributable to shareholders by 129,726.17 million yuan [1] - The board of directors believes that the standards and basis for the impairment provision are reasonable and sufficient, complying with relevant accounting standards, and that the financial information will objectively reflect the company's asset status [1] Group 2 - The company held its 12th board meeting on April 25, 2025, with all six directors present, and the meeting was deemed valid [4][5] - The board approved several reports including the 2024 annual report and the financial settlement report, all of which will be submitted to the 2024 annual general meeting for further approval [10][12][54] Group 3 - The company plans to provide guarantees for its subsidiaries, with a total guarantee amount not exceeding 60 billion yuan for the year 2025, divided into 40 billion yuan for subsidiaries with a debt-to-asset ratio above 70% and 20 billion yuan for those below [58] - The board has approved the guarantee plan, which will be submitted to the shareholders' meeting for approval [59]